GlassScriptPhysician profile
Prashanthi Boppana
NPI 1588630727
$1,439.84
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $829 · 2020: $322 · 2021: $109 · 2022: $76.13 · 2023: $16.97 · 2024: $85.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $86.23 · Education: $16.72.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $86.23 |
| Education | $16.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $289.05 | 2020-2021 | |
| Lilly USA, LLC | $173.78 | 2019-2020 | |
| Ucb, INC. | $169.45 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $138.14 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $133.83 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $121.43 | 2019 | |
| Abbvie INC. | $102.91 | 2022-2024 | |
| Genentech USA, INC. | $53.58 | 2019 | |
| Emd Serono, INC. | $41.71 | 2019-2020 | |
| Livanova USA, INC. | $38.32 | 2022-2023 | Vns Therapy Sentiva Model 1000 Generator |
| Supernus Pharmaceuticals, INC. | $34.04 | 2019 | |
| Jazz Pharmaceuticals INC. | $23.77 | 2019 | |
| Janssen Pharmaceuticals, INC | $22.41 | 2020 | |
| Abbott Laboratories | $21.13 | 2022 | |
| Greenwich Biosciences, INC. | $17.71 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Catalyst Pharmaceuticals, INC. | $16.72 | 2024 | |
| Biogen, INC. | $16.10 | 2019 | |
| Genzyme Corporation | $13.16 | 2019 | |
| Zogenix INC. | $12.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prashanthi Boppana listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.